Safety study of XT-150 for people with ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a new drug called XT-150 for ALS. The goal is to see if it is safe and how the body handles it. It may be an option if you have had ALS symptoms for up to 3 years and have good enough lung function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 80 years old
- Diagnosis of ALS (either sporadic or familial) confirmed by a doctor
- ALS symptoms started within the last 3 years
- Lung function is at least 60% of what is expected for your age, sex, and height
- Not currently on Tofersen, and if on other ALS treatments, dose must be stable
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment made from stem cells (called XS228CN) injected into the spine. It is primarily a safety study, but doctors will also watch for any signs the treatment may slow ALS progression.
This study tests an investigational drug called NB-4746 for people with ALS. The goal is to see if it can slow the progression of the disease. It is for people diagnosed within the last couple of years who are still able to eat and breathe on their own.
This study tests whether a non-invasive brain stimulation technique called HD-tDCS can help people with ALS. It is a randomized trial, meaning participants are assigned by chance to receive the real stimulation or a placebo, to see if it slows disease progression.
This trial tests a new drug called VTx-002 to see if it is safe and tolerable for people with ALS. You may be able to join if you have had symptoms for less than 18 months and have a caregiver who can help.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This study tests an experimental drug called AMX0114 for people recently diagnosed with ALS. It is an early-phase trial to see if the drug is safe and how it affects the body.
Hear when a new Amyotrophic Lateral Sclerosis (ALS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.